← Eichor
Condition: Advance Solid Tumors Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Advance Solid Tumors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and T
NA · 3 location(s) · Fred Hutchinson Cancer Center · NCT07141407A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patien
Phase 1/Phase 2 · 1 location(s) · Shenzhen Ionova Life Sciences Co., Ltd. · NCT07610798Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid
NA · 1 location(s) · Mayo Clinic · NCT07174661Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pemb
Phase 1/Phase 2 · 7 location(s) · Strand Therapeutics Inc. · NCT06249048A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma
Phase 2 · 35 location(s) · Day One Biopharmaceuticals, Inc. · NCT04775485Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
NA · 4 location(s) · Fred Hutchinson Cancer Center · NCT04515810The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease
NA · 1 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT06795815Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objective
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT01365169Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors
Phase 1 · 1 location(s) · Children's National Research Institute · NCT05238792A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 · 6 location(s) · Kivu Bioscience Inc. · NCT07229313An Initial Evaluation of AN8025 in Solid Tumors
Phase 1 · 1 location(s) · Adlai Nortye Biopharma Co., Ltd. · NCT07639047
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.